Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer

NCT04191421 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Adenocarcinoma
Stage IV Pancreatic Cancer AJCC v8

Interventions

BIOLOGICAL: Siltuximab
BIOLOGICAL: Spartalizumab

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]